Revolutionary Dental Material Trioxide Aggregate
ENDOCEM MTA is a revolutionary and next-generation mineral trioxide aggregate product based on the science of pozzolan reactions. The product can be set quickly within 4 minutes, and can be handled easily for consistent outcomes, excellent sealing capabilities and superb biocompatibility. ENDOCEM MTA exhibit high efficacy not only in apical retro-filling and root perforations, but also in vital pulp therapies such as direct pulp capping. The product is supplied in a 300mg package and can be used at a mixing ratio of 300mg / 0.12cc.
Maruchi Co., LTD was established in 2005, and the batch production line was established near Seoul in 2008 to develop and manufacture ENDOCEM mineral trioxide aggregate optimized for vital pulp therapies. Also, the affiliated R&D Institute was established in 2012 in the Korea Institute of Science and Technology for the innovative development of mineral trioxide aggregate products. Maruchi Co., LTD obtained various international certifications for its products, including ISO13485, KGMP and CE. Also, the company was awarded of the international approvals including JPAL in Japan and TGA in Australia. Moreover, Maruchi Co., LTD acquired FDA approval from the US government for its products ENDOCEM Zr and ENDOSEAL. The company possesses international patents regarding the production of advanced dental materials.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods
